// App-Quantinova.ai

OR5‐026 : Should we abandon the APTT for monitoring the anticoagulant effect of unfractionated heparin?

Researchers

Presenter

  • D Jayakody Arachchillage

Principal Investigators

  • S Deplano

  • F Kamani

  • L Tillyer

  • M Laffan

Medical Centers

  • Department of Haematology, Royal Brompton Hospital

  • Department of Histopathology, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Heparin

  • Fibrinogen (IV)

  • Heparin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved